Joseph M Unger Selected Research

Joseph M Unger Research Topics

Disease

37	Neoplasms (Cancer) 03/2024 - 02/2002
28	Breast Neoplasms (Breast Cancer) 01/2023 - 03/2008
13	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 07/2004
9	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2015 - 09/2003
7	Pain (Aches) 11/2022 - 10/2015
7	Arthralgia (Joint Pain) 11/2022 - 06/2015
7	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 08/2014 - 06/2004
5	Melanoma (Melanoma, Malignant) 01/2023 - 02/2002
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 01/2021
5	Peripheral Nervous System Diseases (PNS Diseases) 01/2020 - 07/2013
5	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 12/2013 - 09/2003
4	Lung Neoplasms (Lung Cancer) 11/2023 - 07/2020
4	Lymphoma (Lymphomas) 10/2023 - 06/2004
3	Chronic Disease (Chronic Diseases) 01/2023 - 07/2013
3	Fatigue 01/2021 - 07/2013
3	B-Cell Lymphoma (Lymphoma, B Cell) 01/2015 - 06/2004
2	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 01/2019
2	Osteoarthritis 12/2021 - 10/2015
2	Disease Progression 09/2021 - 10/2013
2	Neoplasm Metastasis (Metastasis) 02/2021 - 01/2017
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 01/2017
2	Hepatitis B 10/2019 - 10/2019
2	Hodgkin Disease (Hodgkin's Disease) 01/2017 - 08/2003
1	Chronic Hepatitis (Chronic Active Hepatitis) 01/2023
1	Diarrhea 01/2023
1	HIV Infections (HIV Infection) 01/2023
1	Virus Diseases (Viral Diseases) 12/2022
1	Osteonecrosis (Kienbock's Disease) 02/2021
1	Multiple Myeloma 01/2021
1	Exanthema (Rash) 07/2020
1	Premature Menopause 01/2019
1	Obesity 01/2019
1	Osteoporosis 01/2019

Drug/Important Bio-Agent (IBA)

10	Aromatase InhibitorsIBA 11/2022 - 06/2015
9	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2020 - 09/2003
7	Hormones (Hormone)IBA 01/2023 - 05/2009
7	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2020 - 09/2003
7	Prednisone (Sone)FDA LinkGeneric 01/2017 - 09/2003
6	taxaneIBA 01/2020 - 07/2013
6	Vincristine (Oncovin)FDA LinkGeneric 01/2015 - 09/2003
5	VaccinesIBA 10/2019 - 04/2002
5	Rituximab (Mabthera)FDA Link 12/2013 - 05/2008
4	IpilimumabIBA 11/2023 - 09/2021
4	Finasteride (Propecia)FDA LinkGeneric 11/2018 - 07/2004
4	Etoposide (VP 16)FDA LinkGeneric 01/2013 - 11/2005
3	NivolumabIBA 11/2023 - 09/2021
3	salicylhydroxamic acid (SHAM)IBA 11/2022 - 06/2015
3	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2018 - 01/2015
2	InterferonsIBA 01/2023 - 11/2005
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2017
2	ErbB Receptors (EGF Receptor)IBA 01/2021 - 07/2020
2	Anaplastic Lymphoma KinaseIBA 01/2021 - 01/2013
2	Paclitaxel (Taxol)FDA LinkGeneric 10/2020 - 12/2017
2	Goserelin (Zoladex)FDA Link 01/2019 - 01/2015
2	Duloxetine Hydrochloride (Cymbalta)FDA Link 01/2019 - 01/2018
2	Estrogen ReceptorsIBA 01/2019 - 01/2018
2	Progesterone Receptors (Progesterone Receptor)IBA 01/2019 - 01/2018
2	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 12/2018 - 10/2015
2	Tamoxifen FDA LinkGeneric 01/2017 - 01/2016
2	Docetaxel (Taxotere)FDA Link 01/2017 - 02/2015
2	AndrogensIBA 05/2016 - 04/2016
2	HLA-A2 Antigen (HLA A2 Antigen)IBA 10/2014 - 04/2002
2	Histocompatibility Antigens Class IIBA 10/2014 - 04/2002
2	MelacineIBA 10/2014 - 04/2002
2	Bevacizumab (Avastin)FDA Link 08/2012 - 05/2009
2	Methotrexate (Mexate)FDA LinkGeneric 01/2009 - 11/2005
2	ParaffinIBA 10/2008 - 10/2007
2	IodineIBA 09/2006 - 09/2003
2	DNA (Deoxyribonucleic Acid)IBA 06/2004 - 02/2002
2	Cancer VaccinesIBA 04/2002 - 04/2002
1	Vitamin E FDA LinkGeneric 01/2023
1	SeleniumIBA 01/2023
1	pembrolizumabIBA 01/2023
1	Immunologic Factors (Immunomodulators)IBA 01/2023
1	Antiviral Agents (Antivirals)IBA 12/2022
1	Carcinoembryonic AntigenIBA 01/2022
1	PlatinumIBA 09/2021
1	Zoledronic Acid (Zometa)FDA Link 02/2021
1	Tyrosine Kinase InhibitorsIBA 01/2021
1	AntioxidantsIBA 10/2020
1	AcidsIBA 01/2020
1	GangliosidesIBA 01/2020
1	gamma- hydroxy- gamma- ethyl- gamma- phenylbutyramide (HEPB)IBA 10/2019
1	Vitamin D FDA LinkGeneric 01/2019
1	Serotonin (5 Hydroxytryptamine)IBA 01/2019
1	CalciumIBA 01/2019
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2019
1	Fluorouracil (Carac)FDA LinkGeneric 01/2019

Therapy/Procedure

34	Therapeutics 11/2023 - 04/2002
24	Drug Therapy (Chemotherapy) 01/2023 - 02/2002
8	Immunotherapy 11/2023 - 04/2002
5	Radiotherapy 01/2015 - 09/2003
4	Adjuvant Chemotherapy 01/2020 - 03/2008
3	Aftercare (After-Treatment) 01/2023 - 01/2020
3	Chemoprevention 01/2018 - 12/2003
2	Castration 01/2017 - 02/2015
2	Stem Cell Transplantation 10/2013 - 04/2008
1	Length of Stay 03/2024
1	Continuity of Patient Care 01/2023
1	Dental Care 02/2021